0 XP   0   0   0

Aspira Pathlab & Diagnostics Ltd
Buy, Hold or Sell?

Should you buy, hold or sell Aspira Pathlab & Diagnostics Ltd?

I guess you are interested in Aspira Pathlab & Diagnostics Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Aspira Pathlab & Diagnostics Ltd

Let's start. I'm going to help you getting a better view of Aspira Pathlab & Diagnostics Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Aspira Pathlab & Diagnostics Ltd even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Aspira Pathlab & Diagnostics Ltd is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Aspira Pathlab & Diagnostics Ltd. The closing price on 2023-01-27 was INR41.40 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Aspira Pathlab & Diagnostics Ltd Daily Candlestick Chart
Aspira Pathlab & Diagnostics Ltd Daily Candlestick Chart
Summary









1. Valuation of Aspira Pathlab & Diagnostics Ltd




Current price per share

INR41.40

2. Growth of Aspira Pathlab & Diagnostics Ltd




Is Aspira Pathlab & Diagnostics Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$1.5m$1m$550.4k35.0%

How much money is Aspira Pathlab & Diagnostics Ltd making?

Current yearPrevious yearGrowGrow %
Making money$548.5k$169.8k$378.6k69.0%
Net Profit Margin22.8%9.1%--

How much money comes from the company's main activities?

3. Financial Health of Aspira Pathlab & Diagnostics Ltd




Comparing to competitors in the industry




  Industry Rankings ()  



Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is very efficient in making profit.
Using its investors money, the company is very efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of Aspira Pathlab & Diagnostics Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Aspira Pathlab & Diagnostics Ltd earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Aspira Pathlab & Diagnostics Ltd to the  industry mean.
  • A Net Profit Margin of 22.8% means that ₹0.23 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Aspira Pathlab & Diagnostics Ltd:

  • The MRQ is 22.8%. The company is making a huge profit. +2
  • The TTM is 22.8%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ22.8%TTM22.8%0.0%
TTM22.8%YOY9.1%+13.7%
TTM22.8%5Y-42.9%+65.7%
5Y-42.9%10Y-95.6%+52.7%
1.1.2. Return on Assets

Shows how efficient Aspira Pathlab & Diagnostics Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Aspira Pathlab & Diagnostics Ltd to the  industry mean.
  • 24.6% Return on Assets means that Aspira Pathlab & Diagnostics Ltd generated ₹0.25 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Aspira Pathlab & Diagnostics Ltd:

  • The MRQ is 24.6%. Using its assets, the company is very efficient in making profit. +2
  • The TTM is 24.6%. Using its assets, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ24.6%TTM24.6%0.0%
TTM24.6%YOY11.7%+12.9%
TTM24.6%5Y-14.6%+39.2%
5Y-14.6%10Y-15.2%+0.6%
1.1.3. Return on Equity

Shows how efficient Aspira Pathlab & Diagnostics Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Aspira Pathlab & Diagnostics Ltd to the  industry mean.
  • 34.9% Return on Equity means Aspira Pathlab & Diagnostics Ltd generated ₹0.35 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Aspira Pathlab & Diagnostics Ltd:

  • The MRQ is 34.9%. Using its investors money, the company is very efficient in making profit. +2
  • The TTM is 34.9%. Using its investors money, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ34.9%TTM34.9%0.0%
TTM34.9%YOY16.6%+18.3%
TTM34.9%5Y-365.4%+400.3%
5Y-365.4%10Y-312.2%-53.2%

1.2. Operating Efficiency of Aspira Pathlab & Diagnostics Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Aspira Pathlab & Diagnostics Ltd is operating .

  • Measures how much profit Aspira Pathlab & Diagnostics Ltd makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Aspira Pathlab & Diagnostics Ltd to the  industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Aspira Pathlab & Diagnostics Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
1.2.2. Operating Ratio

Measures how efficient Aspira Pathlab & Diagnostics Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to  industry mean).
  • An Operation Ratio of 0.90 means that the operating costs are ₹0.90 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Aspira Pathlab & Diagnostics Ltd:

  • The MRQ is 0.901. The company is less efficient in keeping operating costs low.
  • The TTM is 0.901. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.901TTM0.9010.000
TTM0.901YOY1.037-0.136
TTM0.9015Y1.171-0.270
5Y1.17110Y1.007+0.164

1.3. Liquidity of Aspira Pathlab & Diagnostics Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Aspira Pathlab & Diagnostics Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to  industry mean).
  • A Current Ratio of 3.99 means the company has ₹3.99 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Aspira Pathlab & Diagnostics Ltd:

  • The MRQ is 3.994. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.994. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.994TTM3.9940.000
TTM3.994YOY1.929+2.065
TTM3.9945Y1.641+2.353
5Y1.64110Y1.483+0.158
1.3.2. Quick Ratio

Measures if Aspira Pathlab & Diagnostics Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Aspira Pathlab & Diagnostics Ltd to the  industry mean.
  • A Quick Ratio of 3.59 means the company can pay off ₹3.59 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Aspira Pathlab & Diagnostics Ltd:

  • The MRQ is 3.591. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.591. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.591TTM3.5910.000
TTM3.591YOY1.574+2.017
TTM3.5915Y1.251+2.340
5Y1.25110Y1.127+0.125

1.4. Solvency of Aspira Pathlab & Diagnostics Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Aspira Pathlab & Diagnostics Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Aspira Pathlab & Diagnostics Ltd to industry mean.
  • A Debt to Asset Ratio of 0.29 means that Aspira Pathlab & Diagnostics Ltd assets are financed with 29.5% credit (debt) and the remaining percentage (100% - 29.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Aspira Pathlab & Diagnostics Ltd:

  • The MRQ is 0.295. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.295. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.295TTM0.2950.000
TTM0.295YOY0.294+0.001
TTM0.2955Y0.589-0.294
5Y0.58910Y0.591-0.002
1.4.2. Debt to Equity Ratio

Measures if Aspira Pathlab & Diagnostics Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Aspira Pathlab & Diagnostics Ltd to the  industry mean.
  • A Debt to Equity ratio of 41.8% means that company has ₹0.42 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Aspira Pathlab & Diagnostics Ltd:

  • The MRQ is 0.418. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.418. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.418TTM0.4180.000
TTM0.418YOY0.416+0.002
TTM0.4185Y8.377-7.959
5Y8.37710Y7.233+1.144

2. Market Valuation of Aspira Pathlab & Diagnostics Ltd

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Aspira Pathlab & Diagnostics Ltd generates.

  • Above 15 is considered overpriced but always compare Aspira Pathlab & Diagnostics Ltd to the  industry mean.
  • A PE ratio of 17.81 means the investor is paying ₹17.81 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Aspira Pathlab & Diagnostics Ltd:

  • The EOD is 9.556. Very good. +2
  • The MRQ is 17.807. Very good. +2
  • The TTM is 17.807. Very good. +2
Trends
Current periodCompared to+/- 
EOD9.556MRQ17.807-8.252
MRQ17.807TTM17.8070.000
TTM17.807YOY19.938-2.130
TTM17.8075Y7.549+10.258
5Y7.54910Y6.291+1.258
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Aspira Pathlab & Diagnostics Ltd.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Aspira Pathlab & Diagnostics Ltd:

  • The MRQ is 5.515. Seems overpriced? -1
  • The TTM is 5.515. Seems overpriced? -1
Trends
Current periodCompared to+/- 
MRQ5.515TTM5.5150.000
TTM5.515YOY8.691-3.176
TTM5.5155Y7.103-1.588
5Y7.10310Y7.1030.000

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Aspira Pathlab & Diagnostics Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to industry mean).
  • A PB ratio of 6.21 means the investor is paying ₹6.21 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Aspira Pathlab & Diagnostics Ltd:

  • The EOD is 3.332. Neutral. Compare to industry.
  • The MRQ is 6.209. Seems overpriced? -1
  • The TTM is 6.209. Seems overpriced? -1
Trends
Current periodCompared to+/- 
EOD3.332MRQ6.209-2.877
MRQ6.209TTM6.2090.000
TTM6.209YOY3.312+2.898
TTM6.2095Y1.904+4.305
5Y1.90410Y1.587+0.317
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Aspira Pathlab & Diagnostics Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--4.3484.3480%3.988+9%0.207+2004%2.071+110%
Book Value Growth--1.5381.5380%2.188-30%4.004-62%4.004-62%
Book Value Per Share--12.42512.4250%8.078+54%6.315+97%7.161+74%
Book Value Per Share Growth--1.5381.5380%1.975-22%2.809-45%2.809-45%
Current Ratio--3.9943.9940%1.929+107%1.641+143%1.483+169%
Debt To Asset Ratio--0.2950.2950%0.294+0%0.589-50%0.591-50%
Debt To Equity Ratio--0.4180.4180%0.416+0%8.377-95%7.233-94%
Dividend Per Share----0%-0%-0%-0%
Eps--4.3324.3320%1.342+223%-3.193+174%-3.535+182%
Eps Growth--3.2293.2290%2.294+41%2.762+17%2.762+17%
Free Cash Flow Per Share--1.3831.3830%5.225-74%-2.279+265%-4.599+432%
Free Cash Flow Per Share Growth--0.2650.2650%4.536-94%1.850-86%1.850-86%
Free Cash Flow To Equity Per Share--0.0700.0700%3.114-98%1.099-94%1.075-93%
Free Cash Flow To Equity Per Share Growth--0.0220.0220%6.513-100%1.747-99%1.747-99%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--42.562--------
Intrinsic Value_10Y_min--35.540--------
Intrinsic Value_1Y_max--2.009--------
Intrinsic Value_1Y_min--1.952--------
Intrinsic Value_3Y_max--7.756--------
Intrinsic Value_3Y_min--7.294--------
Intrinsic Value_5Y_max--15.576--------
Intrinsic Value_5Y_min--14.161--------
Net Profit Margin--0.2280.2280%0.091+151%-0.429+288%-0.956+519%
Operating Margin----0%-0%-0%-0%
Operating Ratio--0.9010.9010%1.037-13%1.171-23%1.007-11%
Pb Ratio3.332-86%6.2096.2090%3.312+87%1.904+226%1.587+291%
Pe Ratio9.556-86%17.80717.8070%19.938-11%7.549+136%6.291+183%
Peg Ratio--5.5155.5150%8.691-37%7.103-22%7.103-22%
Price Per Share41.400-86%77.15077.1500%26.750+188%20.780+271%17.317+346%
Price To Total Gains Ratio9.522-86%17.74517.7450%6.708+165%12.227+45%12.227+45%
Profit Growth--3.2293.2290%2.326+39%1.552+108%1.552+108%
Quick Ratio--3.5913.5910%1.574+128%1.251+187%1.127+219%
Return On Assets--0.2460.2460%0.117+110%-0.146+159%-0.152+162%
Return On Equity--0.3490.3490%0.166+110%-3.654+1148%-3.122+995%
Revenue Growth--1.2851.2850%1.807-29%2.338-45%2.338-45%
Total Gains Per Share--4.3484.3480%3.988+9%0.207+2004%2.071+110%
Total Gains Per Share Growth--1.0901.0900%3.775-71%1.211-10%1.211-10%
Usd Book Value--1573108.5001573108.5000%1022683.500+54%748606.954+110%745119.138+111%
Usd Book Value Change Per Share--0.0530.0530%0.049+9%0.003+2004%0.025+110%
Usd Book Value Per Share--0.1530.1530%0.099+54%0.078+97%0.088+74%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.0530.0530%0.017+223%-0.039+174%-0.043+182%
Usd Free Cash Flow--175152.000175152.0000%661457.100-74%24349.033+619%20290.861+763%
Usd Free Cash Flow Per Share--0.0170.0170%0.064-74%-0.028+265%-0.057+432%
Usd Free Cash Flow To Equity Per Share--0.0010.0010%0.038-98%0.014-94%0.013-93%
Usd Price Per Share0.509-86%0.9490.9490%0.329+188%0.256+271%0.213+346%
Usd Profit--548506.200548506.2000%169863.000+223%-225469.824+141%-243748.567+144%
Usd Revenue--2403653.7002403653.7000%1870264.200+29%1356901.363+77%1146306.393+110%
Usd Total Gains Per Share--0.0530.0530%0.049+9%0.003+2004%0.025+110%
 EOD+3 -2MRQTTM+0 -0YOY+23 -155Y+27 -1110Y+27 -11

3.2. Fundamental Score

Let's check the fundamental score of Aspira Pathlab & Diagnostics Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-159.556
Price to Book Ratio (EOD)Between0-13.332
Net Profit Margin (MRQ)Greater than00.228
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than13.591
Current Ratio (MRQ)Greater than13.994
Debt to Asset Ratio (MRQ)Less than10.295
Debt to Equity Ratio (MRQ)Less than10.418
Return on Equity (MRQ)Greater than0.150.349
Return on Assets (MRQ)Greater than0.050.246
Total8/10 (80.0%)

3.3. Technical Score

Let's check the technical score of Aspira Pathlab & Diagnostics Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose40.250
Total0/1 (0.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2017-12-312018-12-312019-12-312020-12-312021-12-31
Retained Earnings  -48,58218,566-30,015-24,906-54,92135,136-19,78544,75024,965



Latest Balance Sheet

Balance Sheet of 2021-12-31. Currency in INR. All numbers in thousands.

Summary
Total Assets181,353
Total Liabilities53,458
Total Stockholder Equity127,895
 As reported
Total Liabilities 53,458
Total Stockholder Equity+ 127,895
Total Assets = 181,353

Assets

Total Assets181,353
Total Current Assets71,442
Long-term Assets71,442
Total Current Assets
Cash And Cash Equivalents 2,893
Short-term Investments 2,893
Net Receivables 44,911
Inventory 4,045
Other Current Assets 914
Total Current Assets  (as reported)71,442
Total Current Assets  (calculated)55,656
+/- 15,786
Long-term Assets
Property Plant Equipment 68,243
Goodwill 26,518
Intangible Assets 974
Other Assets -1
Long-term Assets  (as reported)109,911
Long-term Assets  (calculated)95,734
+/- 14,177

Liabilities & Shareholders' Equity

Total Current Liabilities17,887
Long-term Liabilities35,572
Total Stockholder Equity127,895
Total Current Liabilities
Accounts payable 6,096
Other Current Liabilities -2
Total Current Liabilities  (as reported)17,887
Total Current Liabilities  (calculated)6,094
+/- 11,793
Long-term Liabilities
Long term Debt Total 32,746
Long-term Liabilities  (as reported)35,572
Long-term Liabilities  (calculated)32,746
+/- 2,826
Total Stockholder Equity
Common Stock102,930
Retained Earnings 24,965
Total Stockholder Equity (as reported)127,895
Total Stockholder Equity (calculated)127,895
+/-0
Other
Capital Stock152,228
Cash And Equivalents13,544
Cash and Short Term Investments 16,437
Common Stock Shares Outstanding 10,293
Liabilities and Stockholders Equity 181,353
Net Invested Capital 78,596
Net Working Capital 53,555



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
> Total Assets 
148,572
125,319
147,998
143,353
117,758
181,353
181,353117,758143,353147,998125,319148,572
   > Total Current Assets 
39,766
17,892
22,990
32,883
38,801
71,442
71,44238,80132,88322,99017,89239,766
       Cash And Cash Equivalents 
0
0
936
10,000
0
2,893
2,893010,00093600
       Short-term Investments 
0
0
0
10,000
2,755
2,893
2,8932,75510,000000
       Net Receivables 
870
3,548
7,961
6,046
17,027
44,911
44,91117,0276,0467,9613,548870
       Inventory 
1,191
3,694
2,801
2,765
3,667
4,045
4,0453,6672,7652,8013,6941,191
       Other Current Assets 
4,787
1,978
2,026
2,386
662
914
9146622,3862,0261,9784,787
   > Long-term Assets 
0
0
125,008
110,470
78,957
109,911
109,91178,957110,470125,00800
       Property Plant Equipment 
69,395
68,520
61,893
60,361
49,552
68,243
68,24349,55260,36161,89368,52069,395
       Goodwill 
9,424
9,424
26,518
26,518
26,518
26,518
26,51826,51826,51826,5189,4249,424
       Intangible Assets 
1,526
1,109
556
78
1,454
974
9741,454785561,1091,526
       Long-term Assets Other 
0
0
0
0
2
-1
-120000
> Total Liabilities 
89,411
121,971
96,083
105,344
34,613
53,458
53,45834,613105,34496,083121,97189,411
   > Total Current Liabilities 
57,513
16,367
42,096
51,214
20,112
17,887
17,88720,11251,21442,09616,36757,513
       Short-term Debt 
36,105
854
19,649
23,183
0
0
0023,18319,64985436,105
       Short Long Term Debt 
0
0
28,087
31,974
4,839
0
04,83931,97428,08700
       Accounts payable 
0
0
2,881
4,010
6,649
6,096
6,0966,6494,0102,88100
       Other Current Liabilities 
0
0
0
392
783
-2
-2783392000
   > Long-term Liabilities 
0
0
53,987
54,130
14,501
35,572
35,57214,50154,13053,98700
       Long term Debt Total 
31,750
105,031
47,836
51,935
12,522
32,746
32,74612,52251,93547,836105,03131,750
       Capital Lease Obligations Min Short Term Debt
-36,105
-854
-19,649
-11,904
8,338
30,631
30,6318,338-11,904-19,649-854-36,105
> Total Stockholder Equity
59,161
3,348
51,915
38,009
83,145
127,895
127,89583,14538,00951,9153,34859,161
   Common Stock
51,930
51,930
81,930
92,930
102,930
102,930
102,930102,93092,93081,93051,93051,930
   Retained Earnings 
7,231
-48,582
-30,015
-54,921
-19,785
24,965
24,965-19,785-54,921-30,015-48,5827,231
   Capital Surplus 000000
   Treasury Stock000000
   Other Stockholders Equity 000000



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue195,419
Cost of Revenue-31,381
Gross Profit164,038164,038
 
Operating Income (+$)
Gross Profit164,038
Operating Expense-144,748
Operating Income47,37419,290
 
Operating Expense (+$)
Research Development-
Selling General Administrative50,195
Selling And Marketing Expenses-
Operating Expense144,74850,195
 
Net Interest Income (+$)
Interest Income3,082
Interest Expense-3,082
Net Interest Income-2,7790
 
Pretax Income (+$)
Operating Income47,374
Net Interest Income-2,779
Other Non-Operating Income Expenses-
Income Before Tax (EBT)44,59447,374
EBIT - interestExpense = -3,082
44,594
47,676
Interest Expense3,082
Earnings Before Interest and Taxes (ebit)-47,676
Earnings Before Interest and Taxes (ebitda)64,033
 
After tax Income (+$)
Income Before Tax44,594
Tax Provision-0
Net Income From Continuing Ops44,59444,594
Net Income44,594
Net Income Applicable To Common Shares44,594
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-2,779
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
CUBE1.CC
30 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CUBE1.CC.

CUBE1.CC Daily Candlestick Chart
CTSI.CC
30 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of CTSI.CC.

CTSI.CC Daily Candlestick Chart
CTI.CC
30 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of CTI.CC.

CTI.CC Daily Candlestick Chart
CRV1.CC
32 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of CRV1.CC.

CRV1.CC Daily Candlestick Chart
CRU.CC
32 minutes ago

I found you a Golden Cross on the daily chart of CRU.CC.

CRU.CC Daily Candlestick Chart
CRPT.CC
32 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of CRPT.CC.

CRPT.CC Daily Candlestick Chart
CREP.CC
32 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of CREP.CC.

CREP.CC Daily Candlestick Chart
CORN.CC
34 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of CORN.CC.

CORN.CC Daily Candlestick Chart
CORAL.CC
34 minutes ago

I found you a MACD Bearish Hidden Divergence on the daily chart of CORAL.CC.

CORAL.CC Daily Candlestick Chart
CONTENTBOX.CC
34 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of CONTENTBOX.CC.

CONTENTBOX.CC Daily Candlestick Chart
CLV.CC
36 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CLV.CC.

CLV.CC Daily Candlestick Chart
CIV.CC
37 minutes ago

I found you a MACD Bullish Hidden Divergence on the daily chart of CIV.CC.

CIV.CC Daily Candlestick Chart
NGU24-NYM.COMM
7 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NGU24-NYM.COMM.

NGU24-NYM.COMM Daily Candlestick Chart
NGM24-NYM.COMM
7 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NGM24-NYM.COMM.

NGM24-NYM.COMM Daily Candlestick Chart
NGQ24-NYM.COMM
7 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NGQ24-NYM.COMM.

NGQ24-NYM.COMM Daily Candlestick Chart
ISKJ.MCX
7 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ISKJ.MCX.

ISKJ.MCX Daily Candlestick Chart
CHKZ.MCX
7 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CHKZ.MCX.

CHKZ.MCX Daily Candlestick Chart
VSYD.MCX
7 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of VSYD.MCX.

VSYD.MCX Daily Candlestick Chart
VRSB.MCX
7 hours ago

I found you a Golden Cross on the daily chart of VRSB.MCX.

VRSB.MCX Daily Candlestick Chart
TBRU.MCX
7 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of TBRU.MCX.

TBRU.MCX Daily Candlestick Chart
SNGSP.MCX
7 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SNGSP.MCX.

SNGSP.MCX Daily Candlestick Chart
RBCM.MCX
7 hours ago

I found you a Golden Cross on the daily chart of RBCM.MCX.

RBCM.MCX Daily Candlestick Chart